Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may inhibit inflammatory responses by preventing the toll-like receptor 4 (TLR-4)-mediated formation of proinflammatory cytokines.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 43.00 | |
10 mg | In stock | $ 56.00 | |
25 mg | In stock | $ 75.00 | |
50 mg | In stock | $ 72.00 | |
100 mg | In stock | $ 129.00 | |
200 mg | In stock | $ 193.00 | |
500 mg | In stock | $ 323.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 48.00 |
Description | Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may inhibit inflammatory responses by preventing the toll-like receptor 4 (TLR-4)-mediated formation of proinflammatory cytokines. |
Targets&IC50 | DPP4:<10 nM |
In vitro | Alogliptin(SYR-322) is a potent inhibitor of DPP-4 and exhibits greater than 10,000 fold selectivity over the closely related serine proteases DPP-8 and DPP-9. Alogliptin is not an inhibitor of CYP-450 enzymes and does not block the hERG channel at concentrations up to 30 μM. [1] |
In vivo | Alogliptin(SYR-322) produces dose-dependent improvements in glucose tolerance and increases plasma insulin levels in female Wistar fatty rats. [1] Acute administration of alogliptin results in a significant decrease in plasma DPP-4 activity, and increases plasma active GLP-1. Alogliptin improves glucose tolerance at a dose of 0.3 mg/kg and higher, with a dose-dependent increase in plasma IRI, suggesting that improved glucose tolerance results from the ability of alogliptin to enhance insulin secretion. [2] |
Synonyms | SYR 322, Alogliptin(SYR-322)benzoate |
Molecular Weight | 461.51 |
Formula | C25H27N5O4 |
CAS No. | 850649-62-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 63 mg/mL (136.5 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 2 mg/mL (4.33 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Alogliptin Benzoate 850649-62-6 Apoptosis Proteases/Proteasome Ubiquitination DPP-4 Proteasome Ferroptosis inhibit SYR-322 DPP Alogliptin diabetes Dipeptidyl Peptidase Inhibitor SYR 322 Alogliptin(SYR-322)benzoate SYR322 inhibitor